{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:06:46Z","timestamp":1777468006894,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03683-2","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T09:02:45Z","timestamp":1725008565000},"page":"1075-1083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significances of TTF-1, neuroendocrine (chromogranin, synaptophysin, CD56), and keratin (pancytokeratin, CK7, CK5\/6) marker immunostaining in small cell lung cancer"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-7116","authenticated-orcid":false,"given":"Faruk","family":"Tas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akin","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayhan","family":"Erturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"3683_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.soc.2016.02.003","volume":"25","author":"M Zheng","year":"2016","unstructured":"Zheng M. Classification and pathology of lung cancer. Surg Oncol Clin N Am. 2016;25:447\u201368.","journal-title":"Surg Oncol Clin N Am"},{"key":"3683_CR2","first-page":"522","volume":"20","author":"X Wang","year":"2017","unstructured":"Wang X, Zhang Y, Hu M, Wang R, Liu L, Qian K, et al. Prognostic and predictive value of thyroid transcription factor-1, CD56, p40 and other clinical characteristics in small cell lung cancer patients. Chin J Lung Cancer. 2017;20:522\u20137.","journal-title":"Chin J Lung Cancer"},{"key":"3683_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fonc.2020.01161","volume":"10","author":"E Gkika","year":"2020","unstructured":"Gkika E, Benndorf M, Oerther B, Mohammad F, Beitinger S, Adebahr S, et al. Immunohistochemistry and radiomic features for survival prediction in small cell lung cancer. Front Oncol. 2020;10:1161.","journal-title":"Front Oncol"},{"key":"3683_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4067\/S0717-95022020000200247","volume":"38","author":"JY Wang","year":"2020","unstructured":"Wang JY, Wang XM, Xu XY, Li SR, Liu XL. Expression and Significance of CK5\/6, P63, P40, CK7, TTF-1, NapsinA, CD56, Syn and CgA in biopsy specimen of squamous cell carcinoma, adenocarcinoma and small cell lung carcinoma. Int J Morphol. 2020;38:247\u201351.","journal-title":"Int J Morphol"},{"key":"3683_CR5","doi-asserted-by":"crossref","unstructured":"Yakovtsova I, Yanchevskiy O, Chertenko T, Kis A, Oliyinyk A. Immunohistochemical diagnosis and prognosis of small cell lung cancer: the search for new strategies. ScienceRise: Med Sci 2022;1(46):31\u201336","DOI":"10.15587\/2519-4798.2022.253047"},{"key":"3683_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13000-015-0250-z","volume":"10","author":"D Misch","year":"2015","unstructured":"Misch D, Blum T, Boch C, Weiss T, Crolow C, Griff S, et al. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer. Diagn Pathol. 2015;10:21.","journal-title":"Diagn Pathol"},{"key":"3683_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.humpath.2018.05.009","volume":"79","author":"Y Iida","year":"2018","unstructured":"Iida Y, Masuda S, Nakanishi Y, Shimizu T, Nishimaki H, Takahashi M, et al. Clinicopathological characteristics of thyroid transcription factor 1\u2013negative small cell lung cancers. Human Pathol. 2018;79:127\u201334.","journal-title":"Human Pathol"},{"key":"3683_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152706","volume":"215","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wu Y, Li J, Li J, Che G. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis. Pathol Res Pract. 2019;215: 152706.","journal-title":"Pathol Res Pract"},{"key":"3683_CR9","first-page":"5970","volume":"9","author":"R Sun","year":"2016","unstructured":"Sun R, Liu Z, Ding C, L\u00fc W, Zhang J, Wang X, et al. Prognostic value of neuroendocrine markers for predicting survival in patients with small cell lung cancer. Int J Clin Exp Pathol. 2016;9:5970\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"3683_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/ijabmr.IJABMR_66_19","volume":"9","author":"V Bhatti","year":"2019","unstructured":"Bhatti V, Kwatra KS, Puri S, Calton N. Histopathological spectrum and immunohistochemical profile of lung carcinomas: a 9-year study from a tertiary hospital in North India. Int J App Basic Med Res. 2019;9:169\u201375.","journal-title":"Int J App Basic Med Res"},{"key":"3683_CR11","first-page":"465","volume":"120","author":"A Sloman","year":"1996","unstructured":"Sloman A, D\u2019amico F, Yousem SA. Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung. An immunohistochemical study. Arch Pathol Lab Med. 1996;120:465\u201372.","journal-title":"Arch Pathol Lab Med"},{"key":"3683_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.bjc.6690745","volume":"81","author":"L Drivsholm","year":"1999","unstructured":"Drivsholm L, Paloheimo LI, \u00d8sterlind K. Chromogranin A, a significant prognostic factor in small cell lung cancer. Br J Cancer. 1999;81:667\u201371.","journal-title":"Br J Cancer"},{"key":"3683_CR13","first-page":"111","volume":"66","author":"A Badzio","year":"2019","unstructured":"Badzio A, Czapiewski P, Gorczy\u0144ski A, Szczepa\u0144ska-Michalska K, Haybaeck J, Biernat W, et al. Prognostic value of broad-spectrum keratin clones AE1\/AE3 and CAM5.2 in small cell lung cancer patients undergoing pulmonary resection. Acta Biochim Polon. 2019;66:111\u20134.","journal-title":"Acta Biochim Polon"},{"key":"3683_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153311","volume":"217","author":"T Yuan","year":"2021","unstructured":"Yuan T, Sun S, Cao Z, Feng X, Gao Y. Prognostic immunohistochemical markers for small cell lung cancer: a review. Pathol Res Pract. 2021;217: 153311.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"3683_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtho.2016.12.004","volume":"12","author":"E Thunnisen","year":"2017","unstructured":"Thunnisen E, Borczuk AC, Flieder DB, Witte B, Beasley MB, Chung JH, et al. The use of immunohistochemistry improves the diagnosis of small cell lung cancer and its differential diagnosis. An international reproducibility study in a demanding set of cases. J Thorac Oncol. 2017;12(2):334\u201346.","journal-title":"J Thorac Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03683-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T05:44:01Z","timestamp":1742190241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03683-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["3683"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03683-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in compliance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Because this study was retrospective, ethics committee approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}